These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
261 related items for PubMed ID: 23530659
1. Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. Wu CQ, Grandi SM, Filion KB, Abenhaim HA, Joseph L, Eisenberg MJ. BJOG; 2013 Jun; 120(7):801-10. PubMed ID: 23530659 [Abstract] [Full Text] [Related]
2. Commentary on "Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review". Cameron S. BJOG; 2013 Jun; 120(7):811. PubMed ID: 23802311 [No Abstract] [Full Text] [Related]
3. Drospirenone-containing oral contraceptives may increase the risk of venous thromboembolism. Jick SS. Evid Based Nurs; 2014 Jul; 17(3):71. PubMed ID: 24170817 [No Abstract] [Full Text] [Related]
4. Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies. Larivée N, Suissa S, Khosrow-Khavar F, Tagalakis V, Filion KB. BJOG; 2017 Sep; 124(10):1490-1499. PubMed ID: 28276140 [Abstract] [Full Text] [Related]
5. Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters. Larivée N, Suissa S, Coulombe J, Tagalakis V, Filion KB. Drug Saf; 2017 Jul; 40(7):583-596. PubMed ID: 28382493 [Abstract] [Full Text] [Related]
8. Combined oral contraceptives: venous thrombosis. de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, Dekkers OM. Cochrane Database Syst Rev; 2014 Mar 03; 2014(3):CD010813. PubMed ID: 24590565 [Abstract] [Full Text] [Related]
9. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. Parkin L, Sharples K, Hernandez RK, Jick SS. BMJ; 2011 Apr 21; 342():d2139. PubMed ID: 21511804 [Abstract] [Full Text] [Related]
11. Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis. Peragallo Urrutia R, Coeytaux RR, McBroom AJ, Gierisch JM, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, Hasselblad V, Sanders GD, Myers ER. Obstet Gynecol; 2013 Aug 21; 122(2 Pt 1):380-389. PubMed ID: 23969809 [Abstract] [Full Text] [Related]
12. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study. Larivée N, Suissa S, Eberg M, Joseph L, Eisenberg MJ, Abenhaim HA, Filion KB. BJOG; 2017 Oct 21; 124(11):1672-1679. PubMed ID: 27704723 [Abstract] [Full Text] [Related]
18. Hormonal contraception and risk of venous thromboembolism: national follow-up study. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. BMJ; 2009 Aug 13; 339():b2890. PubMed ID: 19679613 [Abstract] [Full Text] [Related]
19. Drospirenone: more cases of thrombosis than with levonorgestrel. Prescrire Int; 2013 Nov 13; 22(143):267. PubMed ID: 24427839 [Abstract] [Full Text] [Related]
20. Drospirenone: high risk of venous thrombosis. Prescrire Int; 2011 Feb 13; 20(113):43-5. PubMed ID: 21488592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]